Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERALD long-term extension of BIIB059 in active systemic lupus erythematosus
jRCT2031220439Phase 3Recruiting
- Sponsor
- Biogen
- Start
- Mar 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of litifilimab in systemic lupus erythematosus (SLE), sponsored by Biogen. Started Mar 2023; status: recruiting.
02
Drugs
litifilimab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2031220439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220439.